Sign in

CIK 0001637715 · <br>Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472309515
Phone
(720) 307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,157
in 2 filings

Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 35 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-04 Jansen Valerie Malyvanh Director Grant or award · Stock Option (right to buy) +7,650 7,650
2026-06-04 Carruthers R Michael Director Grant or award · Stock Option (right to buy) +7,650 7,650
2026-06-04 Ratcliffe Liam Director Grant or award · Stock Option (right to buy) +1,275 1,275
2026-06-04 GREY MICHAEL G Director Grant or award · Stock Option (right to buy) +7,650 7,650
2026-06-04 Mathers Edward T Director Grant or award · Stock Option (right to buy) +7,650 7,650
2026-04-01 Hartley Dylan Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +110,000 110,000
2026-04-01 Agresta Samuel Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +110,000 110,000
2026-04-01 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +110,000 110,000
2026-04-01 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +330,000 330,000
2026-03-31 Ratcliffe Liam Director Grant or award · Stock Option (right to buy) +15,300 15,300
2026-03-23 Leverone Jason A. Chief Financial Officer Sale −301 $4.16 $1K 16,000
2026-03-23 Saccomano Nicholas A President and CEO Sale −86 $4.16 $357 7,333
2025-12-31 Manke Isaac Director Grant or award +5,258 20,583
2025-12-31 Mathers Edward T Director Grant or award +3,911 15,310
2025-12-22 Leverone Jason A. Chief Financial Officer Sale −302 $2.97 $896 16,301
2025-12-22 Saccomano Nicholas A President and CEO Sale −87 $2.97 $258 7,419
2025-09-30 Manke Isaac Director Grant or award +5,545 15,325
2025-09-30 Mathers Edward T Director Grant or award +4,125 11,399
2025-09-22 Leverone Jason A. Chief Financial Officer Sale −303 $2.62 $795 12,603
2025-09-22 Saccomano Nicholas A President and CEO Sale −88 $2.62 $231 3,506

Page 3 of 8 · 154 trades